Affiliation:
1. SmithKline Beecham Pharmaceuticals, Betchworth, Surrey, England.
Abstract
Studies were performed to determine the effects of BRL 42715, a potent beta-lactamase inhibitor, on the activity of cefazolin and piperacillin against experimental intraperitoneal infections caused by either Escherichia coli or Serratia marcescens in rats. Compounds were administered to rats as a continuous infusion of an exponentially diluted solution to simulate in rat plasma the concentration-versus-time curves obtained for humans following intravenous bolus administration. A simulated 1-g dose of cefazolin was ineffective in reducing the bacterial counts in blood and peritoneal fluid samples of animals infected with S. marcescens US20, which produced class Ia beta-lactamase, and as a result, mortality was similar to that of infected controls. Similarly, a simulated 2-g dose of piperacillin was ineffective in reducing bacterial numbers and mortality in animals infected with E. coli 41548, producing a TEM-1 beta-lactamase. However, when the antibiotics were coadministered with BRL 42715, bacterial numbers were reduced significantly and all animals survived at least 16 h after infection. These data demonstrate the ability of BRL 42715 to potentiate the activity of cefazolin and piperacillin against beta-lactamase-producing bacteria that would otherwise be resistant to these antibiotics and illustrate the application of a model to simulate human serum concentrations in conscious rats.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference13 articles.
1. Bennett I. S. G. Brooks N. J. P. Broom K. Coleman S. Coulton R. A. Edmundson D. R. J. Griffin J. B. Harbridge N. F. Osborne I. Stirling-Francois and G. Walker. 1988. BRL 42715: a new potent broad spectrum P-lactamase inhibitor. Synthesis and structure-activity relationships of C6-substituted methylene penems. Program Abstr. 28th Intersci. Conf. Antimicrob. Agents Chemother. abstr. 118.
2. Comparative pharmacokinetics of cefazolin, cephalothin, cephacetril, and cephapirine after intravenous administration;Bergan T.;Chemotherapy,1977
3. In vitro evaluation of BRL 42715, a novel 3-lactamase inhibitor;Coleman K.;Antimicrob. Agents Chemother.,1989
4. Comparative effects of amoxycillin and ampicillin in the treatment of experimental mouse infections;Comber K R;Antimicrob. Agents Chemother.,1975
5. Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections;Gerber A. U.;Scand J. Infect. Dis. Suppl.,1991
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献